Carregant...
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review
BACKGROUND: Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer therapy approvals. The aim of this review was to evaluate the methodology of HRQoL analysis and reporting in phase III clinical trials of first-line chemotherapy in advanced non-small cell lung cancer...
Guardat en:
| Publicat a: | BMC Cancer |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758022/ https://ncbi.nlm.nih.gov/pubmed/26892541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2152-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|